Skip to main content

WIRB-Copernicus Group Thought Leaders to Present Four Sessions at Annual AAHRPP Conference

Princeton, N.J., May 9, 2017: WIRB-Copernicus Group® (WCGTM), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, announced today that three of its leaders will present at the Association for the Accreditation of Human Research Protection Programs (AAHRPP) Conference taking place in Detroit, MI, May 9-11, 2017.

WCG Chief Compliance Officer David G. Forster, JD, MA, CIP, will present “Digital and Emerging Technologies in Clinical Trials: Ethical and Regulatory (FDA) Guidance” on Wednesday, May 10 at 10:30 am CST. His co-presenter will be Elizabeth Buchanan, PhD, from the University of Wisconsin-Stout.

“Clinical research participants play an invaluable role in the development of innovative new therapies. It is imperative that their contribution is duly recognized and that appropriate safeguards are implemented to protect them,” said Mr. Forster.

On Thursday, May 11 at 10:45 am CST, WCG Vice President, Process and Strategic Improvement, Jeffrey A. Cooper, MD, MMM, will speak on “Maintaining a Robust HRPP between Accreditation Cycles.” Later, Dr. Cooper will present on the “New Common Rule” during the Flexibility Coalition Lunch Meeting at 12:00 pm CST.

WCG Vice President of Quality Management David Borasky, MPH, CIP, will partner with Jonathan M. Green, MD, of Washington University at St. Louis to deliver “Can We Measure IRB Quality?: Identifying the Right Metrics to Increase Consistency and Improve Results” on Thursday, May 11 at 1:00 pm CST.

WCG senior staff members will be available in the AAHRPP exhibit hall to discuss the new Western IRB (WIRB) NIH Single Review SolutionTM which helps institutions prepare for the NIH policy directing a Single Review Mandate for multicenter clinical trials. As the long-standing leader in supporting IRB review among 2,300 institution clients, and the chosen partner to over 175 contracted Academic Medical Centers, WIRB has an extensive background reviewng clinical trials funded by NIH.

For more information about the AAHRPP Conference, please visit

About WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research. The industry’s first clinical services organization (CSO), WCG enables biopharmaceutical companies, CROs and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human subject protections. For more information, please visit or follow us on Twitter @WCGClinical

About WCG

WCG is a global leader of solutions that measurably improve and accelerate clinical research. Biopharmaceutical and medical device companies, contract research organizations (CROs), research institutions, and sites partner with us for our unmatched expertise, data intelligence, and purpose-built technology to make informed decisions and optimize study outcomes, while maintaining the highest standards of human participant protection. WCG raises the bar by pioneering new concepts, reimagining processes, fostering compliance and safety, and empowering those who perform clinical trials to accelerate the delivery of medical therapies and devices that improve lives. For more information, please visit or follow us on LinkedIn or Twitter @WCGClinical.